Amanda has 6 years’ experience in rare disease market access policy. She has led a number of projects related to shaping a supportive policy environment for medicines for rare and severe diseases. She holds a PhD in health psychology and worked on the orphan medicinal products workstream of the Horizon 2020 project ‘IMPACT-HTA: Improved methods and actionable tools for enhancing HTA.’
Featured
Prescient Intelligence
Discover our portfolio of AI-powered assessments and intelligent tools designed to support better strategic decisions.
News and insights
Featured
Strategy that learns: Rethinking brand planning for a changing environment
Explore why the strongest brand strategies continue beyond annual planning.
Discover The Prescient Pharma Brand Plan Impact Index
Helping senior leaders strengthen strategy and drive better business performance.
The Four Positioning Challenges Every Pharma Launch Team Must Overcome
Discover four positioning challenges that every pharma launch team should address.
Careers
Work with us
If you're looking to stretch your thinking, lead with purpose, and be part of a culture that values curiosity, accountability and trust, you're in the right place.
